Evidence map›Paper›PMID 41943981›Full record

ArticleJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology2026

Dual Beneficial Effects of Topical l-Glutamine on Oral Mucositis in 5-Fluorouracil-Treated Mice.

Juliana Francisca Grossi Heleno, Igor de Campos Fontes, Leticia Cristine Cardoso Dos Santos, Victor Prokop Gonçalves Campos, Iury Berckmann Freitas Gomes, Derek William Gilroy, Silvia Passos Andrade, Paula Peixoto Campos

Abstract read
In one paragraph

Article in Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juliana Francisca Grossi HelenoDepartment of General Pathology, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Igor de Campos FontesDepartment of General Pathology, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Leticia Cristine Cardoso Dos SantosDepartment of General Pathology, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Victor Prokop Gonçalves CamposDepartment of General Pathology, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Iury Berckmann Freitas GomesDepartment of General Pathology, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Derek William GilroyDepartment of Ageing, Rheumatology & Regenerative Medicine, University College London, London, UK.
Silvia Passos AndradeDepartment of Physiology and Biophysics, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Paula Peixoto CamposDepartment of General Pathology, Biological Science Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil.

Funding

Fundação de Amparo à Pesquisa do Estado de Minas Gerais RED-00213-23Fundação de Amparo à Pesquisa do Estado de Minas Gerais RED-00570-16
6 · The paper itself

Abstract

backgroundOral mucositis is a severe health and economic problem that occurs in about 40%-90% of patients undergoing cancer treatments. Systemic or topical application of l-glutamine has been shown to improve mucosal healing and ameliorate oral mucositis (OM) symptoms according to clinical score systems. To further establish the beneficial effects of this amino acid, our study examined the actions of topical application of l-glutamine on inflammation and mucosal healing markers in tongue lesions in mice treated with 5-Fluorouracil.

methodsThe animals received 3 doses of the chemotherapeutic agent (non-consecutive days) at concentrations of 60, 40, and 40 mg/kg, respectively. Tongue lesions were made by acetic acid (bolus injection) on the ventral face. Ten mg/50 μL of l-glutamine were applied at the site of the lesion in the treated group (n = 15) twice a day for 5 days; the control group (n = 15) received filtered water. On day 6, the animals were euthanized, the tongues removed, and processed for inflammatory and fibrogenic markers.

resultsThe treatment decreased myeloperoxidase (MPO) and N-acetyl-β-glucosaminidase (NAG) activities, tumor necrosis factor alpha levels (TNF-α), and mast cell numbers at the site of the lesions. The amino acid was able to decrease the number of Ki-67 positive cells in the treated group. There was increased mucosal remodeling through collagen deposition in the treated group.

conclusionTopical application of l-glutamine acted on multiple axes of OM, modulating inflammation and tissue remodeling in immunosuppressed mice.

Indexed as

Antimetabolites, AntineoplasticFluorouracilGlutamineStomatitisAcetylglucosaminidaseAdministration, TopicalAnimalsKi-67 AntigenMaleMicePeroxidaseTongueTumor Necrosis Factor-alphaWound HealingAcetylglucosaminidaseAntimetabolites, AntineoplasticFluorouracilGlutamineKi-67 AntigenPeroxidaseTumor Necrosis Factor-alphainflammationl‐glutamineremodelingtongue lesions

Identifiers

PMID41943981
PMCPMC13333535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.